Plex Pharmaceuticals, Inc. SBIR Phase I Award, February 2020
A SBIR Phase I contract was awarded to Plex Pharmaceuticals, Inc. in February, 2020 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.